GlaxoSmithKline Offers $2.6 Billion To Buy Human Genome Sciences | April 23, 2012 Issue - Vol. 90 Issue 17 | Chemical & Engineering News
 
 
0
Facebook
Volume 90 Issue 17 | p. 7 | News of The Week
Issue Date: April 23, 2012

GlaxoSmithKline Offers $2.6 Billion To Buy Human Genome Sciences

Department: Business
Keywords: pharmaceuticals, oncology, ovarian cancer

GlaxoSmithKline has made an unsolicited $2.6 billion bid for its long-standing partner Human Genome Sciences. The biotech firm has rejected the bid as too low and has hired Goldman Sachs and Credit Suisse to explore its options, including a sale to GSK or another firm.

GSK and HGS have been drug development and marketing partners since 1993, just two years after HGS was founded. To date, only one product . . .

You Do Not Have Access to C&EN Protected Content.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society